Janice M. Reichert

Janice M. Reichert publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Janice M. Reichert sits on this spectrum.

Janice M. Reichert D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Janice M. Reichert sits on this spectrum.

Best Publications

• Development trends for human monoclonal antibody therapeutics

  Unknown

  1280
  Citations

• Bispecific antibodies: a mechanistic review of the pipeline.

  Aran F Labrijn;Maarten L Janmaat;Janice M Reichert;Paul W H I Parren

  1270
  Citations

• Monoclonal antibody successes in the clinic

  Unknown

  1022
  Citations

• Antibody–drug conjugates come of age in oncology

  Unknown

  753
  Citations

• Development trends for monoclonal antibody cancer therapeutics

  Unknown

  570
  Citations

• Antibodies to watch in 2019.

  Unknown

  555
  Citations

• Marketed therapeutic antibodies compendium

  Unknown

  525
  Citations

• Antibodies to watch in 2020.

  Unknown

  458
  Citations

• Recombinant protein therapeutics—success rates, market trends and values to 2010

  Unknown

  444
  Citations

• Development trends for therapeutic antibody fragments.

  Unknown

  408
  Citations

• Monoclonal antibodies as innovative therapeutics.

  Unknown

  357
  Citations

• The present and future of bispecific antibodies for cancer therapy.

  Unknown

  347
  Citations

• Antibody-based therapeutics to watch in 2011.

  Unknown

  343
  Citations

• Antibodies to watch in 2022

  Unknown

  329
  Citations

• Antibodies to watch in 2017

  Unknown

  317
  Citations

• Antibodies to watch in 2018

  Unknown

  313
  Citations

• Antibodies to watch in 2021.

  Unknown

  288
  Citations

• Antibodies to watch in 2023

  Unknown

  259
  Citations

• Monoclonal antibodies in the clinic.

  Unknown

  257
  Citations

• Marketing approval of mogamulizumab: A triumph for glyco-engineering

  Alain Beck;Janice M. Reichert

  232
  Citations